ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 135 filers reported holding ANIKA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $309,000 | +8.0% | 7,468 | +35.2% | 0.03% | +8.0% |
Q4 2019 | $286,000 | -23.3% | 5,524 | -18.6% | 0.02% | -21.9% |
Q3 2019 | $373,000 | -10.1% | 6,790 | -33.6% | 0.03% | -8.6% |
Q2 2019 | $415,000 | -77.1% | 10,221 | -71.9% | 0.04% | -62.0% |
Q1 2018 | $1,809,000 | -7.6% | 36,393 | +0.2% | 0.09% | -8.0% |
Q4 2017 | $1,957,000 | -18.4% | 36,304 | -12.2% | 0.10% | -24.2% |
Q3 2017 | $2,399,000 | +33.4% | 41,356 | +13.4% | 0.13% | +29.4% |
Q2 2017 | $1,799,000 | +14.3% | 36,459 | +0.6% | 0.10% | +10.9% |
Q1 2017 | $1,574,000 | -21.4% | 36,230 | -11.4% | 0.09% | -27.0% |
Q4 2016 | $2,002,000 | -18.1% | 40,898 | -19.9% | 0.13% | -19.2% |
Q3 2016 | $2,443,000 | -12.6% | 51,057 | -2.0% | 0.16% | -18.3% |
Q2 2016 | $2,796,000 | +25.5% | 52,117 | +4.6% | 0.19% | +18.6% |
Q1 2016 | $2,228,000 | +4.7% | 49,825 | -10.6% | 0.16% | 0.0% |
Q4 2015 | $2,127,000 | +828.8% | 55,735 | +654.6% | 0.16% | +600.0% |
Q3 2015 | $229,000 | -74.9% | 7,386 | -73.3% | 0.02% | -75.5% |
Q2 2015 | $914,000 | – | 27,675 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |